Physician profile
Michael Scott Beasley
NPI 1306889035
$3,115.52
in general payments reported to CMS, 2019-2025
19 companies · $347 in 2025
The $347 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $449 · 2020: $143 · 2021: $382 · 2022: $73.42 · 2023: $1,403 · 2024: $318 · 2025: $347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,003 · Travel and Lodging: $967 · Education: $98.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,003.11 |
| Travel and Lodging | $966.63 |
| Education | $98.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,096.54 | 2021-2025 | Propel, Stealthstation S8 Platform |
| Genzyme Corporation | $586.01 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $454.18 | 2019-2025 | Dupixent |
| Acclarent, INC | $205.39 | 2019-2021 | |
| Intersect Ent, INC. | $157.35 | 2019 | |
| Neurent Medical Limited | $92.34 | 2022-2023 | Neuromark Device, Neuromark Radiofrequency Console |
| Inspire Medical Systems, INC. | $83.51 | 2025 | Inspire |
| Olympus America INC. | $60.81 | 2021-2023 | Olympus |
| Smith+Nephew, INC. | $57.93 | 2019-2023 | Coblation |
| Glaxosmithkline, LLC. | $57.58 | 2023-2025 | Nucala |
| 3nt Medical | $50.77 | 2023-2024 | |
| Checkpoint Surgical, INC | $50.00 | 2020 | |
| Aerin Medical INC. | $43.95 | 2019-2020 | |
| Alk-Abello, INC | $32.36 | 2019 | |
| Integra Lifesciences Corporation | $23.48 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Enterprises LLC | $18.54 | 2019 | |
| Optinose US, INC. | $17.75 | 2019 | |
| Shire North American Group INC | $13.73 | 2019 | |
| Cook Medical LLC | $13.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Beasley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.